Beximco Pharmaceuticals Limited (BST:R2WA)

Beximco Pharmaceuticals Revenue

Beximco Pharmaceuticals had revenue of 12.30B BDT in the quarter ending December 31, 2024, with 12.80% growth. This brings the company's revenue in the last twelve months to 46.34B, up 11.26% year-over-year. In the fiscal year ending June 30, 2024, Beximco Pharmaceuticals had annual revenue of 44.39B with 13.05% growth.

• Revenue (ttm): 46.34B BDT
• Revenue Growth: +11.26%
• P/S Ratio: 0.72
• Revenue / Employee: 41.30M BDT
• Employees: 1,122
• Market Cap: 269.11M EUR

Revenue Chart

* This company reports financials in BDT.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	44.39B	5.12B	13.05%
Jun 30, 2023	39.27B	4.60B	13.26%
Jun 30, 2022	34.67B	5.18B	17.55%
Jun 30, 2021	29.49B	3.88B	15.16%
Jun 30, 2020	25.61B	2.80B	12.25%